Page 30 - Read Online
P. 30

Jubouri et al. Vessel Plus 2023;7:5  https://dx.doi.org/10.20517/2574-1209.2022.49  Page 9 of 13

               Table 3. Summary of the technical success and target vessel patency subsection findings
                Study               Device           Cohort size      Technical success rate (%)
                Singh et al. [40]   RELAY™           148              99.3
                      [41]
                Alsafi et al.       RELAY™           21               100
                      [47]
                RESTORE I           RELAY™           307              97.7
                       [48]
                RESTORE II          RELAY™           173              97.1
                       [42]
                Azuma et al.        Najuta™          393              99.2
                Sato et al. [43]    Najuta™          37               97.3
                        [44]
                Iwakoshi et al.     Najuta™          32               91
                Spear et al. [38]   Cook Zenith™     27               100
                       [45]
                Roselli et al.      Valiant™         9                100

               Table 4. Summary of the mortality subsection findings
                                                                         Mean follow-up period and mortality rate
                Study          Device           Cohort size  Early mortality
                                                                       Follow-up        Overall Mortality
                Singh et al. [40]  RELAY™       148       2.7% (n = 4)  2 years         2.7% (n = 4)
                      [41]
                Alsafi et al.  RELAY™           21        9.5% (n = 2)  36 (3-183) weeks  19% (n = 4)
                RESTORE I [47]  RELAY™          307       7.2% (n = 19)  -
                       [48]
                RESTORE II     RELAY™           173       4.0% (n = 7)  2 years         6.4% (n = 11)
                Azuma et al. [42]  Najuta™      393       1.5% (n = 6)  -
                      [43]
                Sato et al.    Najuta™          37        0%           2.9 ± 2.9 years  11.1% (n = 4)
                      [38]
                Spear et al.   Cook Zenith™     27        0%           1 year           3.7% (n = 1)
                O’Callaghan et al. [49]  Cook Zenith™ Custom  15  7% (n = 1)  -
                               Cook Zenith™     18        18% (n = 3)
                               Non-Custom


               Table 5. Summary of the neurological injury subsection findings
                Study               Device         Cohort size   Stroke (%)   Paraplegia (%)    SCI (%)
                      [41]
                Alsafi et al.       RELAY™         21            14           5                 -
                Tan et al. [54]     RELAY™         148           4.1          -                 -
                      [47]
                RESTORE I           RELAY™         307           1.6          2                 -
                RESTORE II [48]     RELAY™         173           0.6          2.9               -
                       [42]
                Azuma et al.        Najuta™        393           1.8          0.8               -
                Sato et al. [43]    Najuta™        37            16.7         2.8               -
                        [44]
                Iwakoshi et al.     Najuta™        32            3.1          -                 3.1
                          [49]
                O’Callaghan et al.  Cook Zenith™   33            6            -                 6
                Spear et al. [38]   Cook Zenith™   27            7.4          -                 7.4
                       [45]
                Roselli et al.      Valient™       9             0            -                 -

               Reintervention
               The need for reintervention is a well-known aspect of endovascular aortic repair, especially in comparison
               to OSR. Reintervention is typically indicated in cases involving postoperative retrograde dissection,
                                           [40]
               endoleak, or endograft migration . Type 1a endoleak, in particular, is suggestive of suboptimal proximal or
               distal sealing, or graft migration, and is therefore a familiar complication in the context of endovascular
                        [40]
               arch repair .
   25   26   27   28   29   30   31   32   33   34   35